益安生醫Urocross獲臺上市許可與朝陽科大獲SGS永續獎
Panion Medical’s Urocross Receives Taiwan Market Approval; Chaoyang University of Technology Wins SGS Sustainability Award
益安生醫旗下攝護腺治療醫材Urocross取得臺灣上市許可,持續全球佈局;朝陽科大則獲SGS永續社會獎,成為全臺唯一獲獎大專院校。
Panion Medical’s prostate treatment device, Urocross, has received market approval in Taiwan, marking a step forward in its global expansion. Meanwhile, Chaoyang University of Technology has been honored with the SGS Sustainable Society Award, becoming the only higher education institution in Taiwan to receive this recognition.
益安生醫(6499)於2026年11月4日正式對外宣佈,旗下專門治療良性攝護腺肥大(BPH)的創新微創醫材「Urocross」,已順利取得臺灣衛生福利部核發的上市許可。此項進展是繼該產品於2026年3月獲得美國食品藥物管理局(FDA)510(k)上市許可,並於同年10月在美國完成首例商業應用後的重大里程碑,標誌著益安生醫正式啟動該項醫材在臺灣本土市場的商業化程式。
Panion Medical (6499) officially announced on November 4, 2026, that "Urocross," its innovative minimally invasive medical device designed for the treatment of benign prostatic hyperplasia (BPH), has successfully received market approval from the Taiwan Food and Drug Administration (TFDA). This development follows the product's 510(k) clearance from the U.S. Food and Drug Administration (FDA) in March 2026 and its first commercial application in the United States in October of the same year, marking a significant milestone as Panion Medical initiates the commercialization process for the device in the domestic Taiwanese market.
與此同時,教育界亦傳出永續發展佳績,朝陽科技大學在2026年SGS ESG Awards中,憑藉長期投入高齡照護、教育平權及地方創生等社會共融實踐,獲頒「永續社會獎」,成為全臺唯一獲此殊榮的大專校院。
Simultaneously, positive news has emerged from the education sector. Chaoyang University of Technology (CYUT) was awarded the "Sustainable Society Award" at the 2026 SGS ESG Awards, recognizing its long-term commitment to social inclusion practices, including elderly care, educational equity, and local revitalization. It is the only higher education institution in Taiwan to receive this honor.
根據益安生醫公開資訊,Urocross醫材的技術核心在於提供良性攝護腺肥大患者一種微創治療選擇。鑑於臺灣社會結構正快速邁向超高齡化,良性攝護腺肥大已成為中高齡男性極為普遍的健康議題。醫學文獻統計顯示,約有半數的60歲男性存在組織學上的攝護腺增生現象,而隨著年齡增長至70歲以上,其盛行率更攀升至70%左右。
According to public information from Panion Medical, the core technology of the Urocross device lies in providing a minimally invasive treatment option for patients with BPH. Given that Taiwan's social structure is rapidly moving toward a super-aged society, BPH has become an extremely common health issue among middle-aged and elderly men. Medical literature statistics indicate that approximately half of men aged 60 exhibit histological prostate enlargement, and as age increases to over 70, the prevalence rises to approximately 70%.
益安生醫表示,取得臺灣許可後,公司將立即啟動產品供應鏈整合、銷售通路佈建,以及針對醫療專業人員的教育訓練工作,確保臨床應用能順利銜接,以因應臺灣日益增長的高齡醫療需求。
Panion Medical stated that following the receipt of Taiwan's approval, the company will immediately initiate supply chain integration, sales channel development, and educational training for medical professionals to ensure a smooth transition for clinical application, thereby addressing Taiwan's growing demand for geriatric medical care.
在教育與社會實踐領域,朝陽科技大學此次獲獎,主要歸功於其在落實聯合國永續發展目標(SDGs)上的長期努力。校方代表、校長鄭道明指出,朝陽科大的永續策略涵蓋了弱勢學生助學、兒少培力、高齡關懷,以及對性別平等與教職員福祉的重視。透過將專業人才培育與地方創生計畫結合,朝陽科大試圖在校園內營造多元友善環境,並將永續理念擴散至社會層面。此次獲得SGS永續社會獎,不僅是對該校推動社會共融成果的肯定,亦反映出高等教育機構在回應不同世代社會需求時,所扮演的關鍵角色。
In the field of education and social practice, Chaoyang University of Technology's award is primarily attributed to its long-term efforts in implementing the United Nations Sustainable Development Goals (SDGs). University President Cheng Tao-ming noted that CYUT's sustainability strategy encompasses financial aid for disadvantaged students, youth empowerment, elderly care, and a strong emphasis on gender equality and staff welfare. By integrating professional talent cultivation with local revitalization projects, CYUT aims to foster a diverse and friendly environment on campus while extending sustainable concepts to the social level. Receiving the SGS Sustainable Society Award is not only an affirmation of the university's achievements in promoting social inclusion but also reflects the critical role higher education institutions play in responding to the needs of different generations in society.
儘管上述兩則新聞分別屬於醫療產業與教育社會領域,但兩者皆反映出當前臺灣社會對於「高齡化挑戰」的積極應對。益安生醫的醫材技術直接針對高齡男性常見疾病提供解決方案,而朝陽科大的社會實踐則側重於高齡關懷與跨世代共融。兩者在不同維度上,共同回應了臺灣邁入超高齡社會後的資源分配與服務需求。對於醫療產業而言,Urocross的匯入預計將改變現有攝護腺肥大的微創治療市場格局;對於高等教育界而言,朝陽科大的模式則為其他院校在執行ESG策略時,提供了具體的實踐參考路徑。
Although these two news items belong to the medical and educational/social sectors respectively, both reflect the proactive response of current Taiwanese society to the "challenges of an aging population." Panion Medical's device technology provides direct solutions for common diseases in elderly men, while Chaoyang University of Technology's social practice focuses on elderly care and intergenerational inclusion. Together, they address resource allocation and service needs in different dimensions as Taiwan enters a super-aged society. For the medical industry, the introduction of Urocross is expected to change the existing market landscape for minimally invasive BPH treatment; for the higher education sector, the CYUT model provides a concrete path for other institutions to follow when implementing ESG strategies.
然而,需注意的是,醫療器材的商業化推廣受限於醫療體系內的採購流程、醫師臨床習慣的轉變,以及健保給付制度的審核,Urocross在臺灣市場的實際普及速度仍有待市場驗證。同樣地,朝陽科大在永續社會獎項中所展現的實踐成果,雖然在評鑑中獲得肯定,但其針對高齡照護與社會共融的長期影響力,仍需透過後續的社會影響力評估與資料追蹤,方能確保其政策與活動能持續產生正面效益,而非僅止於單一年度的獎項榮譽。
However, it should be noted that the commercial promotion of medical devices is constrained by procurement processes within the medical system, shifts in clinical habits among physicians, and the review mechanisms of the National Health Insurance (NHI) reimbursement system; therefore, the actual speed of Urocross's adoption in the Taiwan market remains to be verified. Similarly, while the practical achievements demonstrated by CYUT in the Sustainable Society Award have been recognized in evaluations, its long-term impact on elderly care and social inclusion still requires subsequent social impact assessments and data tracking to ensure that its policies and activities continue to generate positive benefits, rather than being limited to a single year's award honor.
社會大眾與相關產業在解讀這些訊息時,應避免將單一商業許可或單一獎項視為解決所有社會高齡化問題的終極方案。
When interpreting this information, the general public and relevant industries should avoid viewing a single commercial approval or a single award as the ultimate solution to all problems associated with an aging society.
後續觀察重點在於,益安生醫後續在臺灣醫療院所的鋪貨進度,以及該產品在臨床應用後,患者對於微創治療的滿意度與術後效果回饋。此外,朝陽科大在獲得永續社會獎後,是否能將此模式進一步推廣至其他地區,並與地方政府或醫療機構形成更緊密的產學合作,以擴大其在高齡照護領域的社會影響力,將是未來觀察教育與社會政策發展的重要指標。隨著臺灣高齡人口比例持續攀升,產業界與學術界如何透過創新技術與社會參與來緩解人口結構變遷帶來的壓力,將成為未來數年內持續關注的焦點。
Key areas for future observation include Panion Medical's progress in distributing the product to medical institutions in Taiwan, as well as patient satisfaction and post-operative feedback regarding the minimally invasive treatment following clinical application. Furthermore, whether CYUT can further promote this model to other regions after receiving the Sustainable Society Award, and whether it can form closer industry-academia collaborations with local governments or medical institutions to expand its social influence in the field of elderly care, will be important indicators for observing the development of education and social policy. As the proportion of Taiwan's elderly population continues to rise, how the industrial and academic sectors mitigate the pressures brought about by demographic changes through innovative technology and social participation will remain a focal point in the coming years.